| Died | % | Survived | % | P value |
---|---|---|---|---|---|
 | n = 65 | 49.62% | n = 66 | 50.38% |  |
Age, yrs | Â | Â | Â | Â | Â |
Mean [SD] | 61.9 [17.4] | Â | 55.2 [14.7] | Â | Â |
Median (IQR) | 63 (51, 76) | Â | 56 (45, 66) | Â | 0.014 |
Gender, male | 32 | 49.23% | 32 | 48.48% | 0.932 |
Comorbidities | Â | Â | Â | Â | Â |
CHF | 24 | 36.92% | 14 | 21.21% | 0.048 |
COPD | 23 | 35.38% | 17 | 25.76% | 0.232 |
CLD | 10 | 15.38% | 3 | 4.55% | 0.038 |
DM | 26 | 40.00% | 12 | 18.18% | 0.006 |
CKD | 22 | 33.85% | 10 | 15.15% | 0.013 |
CA | 13 | 20.00% | 13 | 19.70% | 0.965 |
Charlson | Â | Â | Â | Â | Â |
Mean [SD] | 5.3 [3.6] | Â | 3.7 [3.3] | Â | Â |
Median (IQR) | 5 (2, 8) | Â | 3 (1, 6) | Â | 0.009 |
Admission source | Â | Â | Â | Â | Â |
Home | 31 | 47.69% | 32 | 48.48% | 0.928 |
Another hospital | 15 | 23.08% | 21 | 31.82% | 0.262 |
NH/ECF | 16 | 24.62% | 11 | 16.67% | 0.261 |
Unknown | 3 | 4.62% | 2 | 3.03% | 0.680 |
HAC RFs | Â | Â | Â | Â | Â |
Dialysis | 18 | 28.12% | 10 | 15.15% | 0.072 |
Immune suppression | 19 | 29.23% | 15 | 22.73% | 0.396 |
Prior hospitalization | 47 | 72.31% | 46 | 69.70% | 0.742 |
Prior antibiotics | 49 | 75.38% | 38 | 57.58% | 0.031 |
HABSIa | 47 | 72.31% | 33 | 50.00% | 0.009 |